Metabolic dysfunction-associated steatohepatitis (MASH): intersections with type 2 diabetes and insulin resistance
Abstract
Metabolic dysfunction-associated fibrotic/steatotic liver disease (MASLD) and its progressive inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), are increasingly recognized as disorders of failed metabolic, immune, vascular, and reparative integration rather than as simple hepatic fat accumulation. Hepatic insulin resistance is a central pathogenic lesion because it permits persistent gluconeogenesis while maintaining or amplifying de novo lipogenesis, thereby linking adipose tissue dysfunction, lipotoxic hepatocyte stress, innate immune activation, endothelial injury, and fibrogenesis. This review provides an integrated framework for MASLD/MASH pathogenesis by discussing concrete preclinical and clinical examples across hepatic insulin resistance, inflammatory amplification, neutrophil biology, CXCR1/2 pathways, triglycerides, and peroxisome proliferator-activated receptor biology. Furthermore, it introduces how sphingosine-1-phosphate signaling, mesenchymal stromal cell biology, and endogenous stromal repair failure could be a functional part of this overall integration of dyslipidemia/insulin resistance-driven/conditioned MASLD/MASH. For each axis, the review summarizes observed preclinical and clinical outcomes, identifies limitations that have constrained translation, and proposes possible next steps for biomarker-enriched therapeutic development. The central conclusion is that future MASLD/MASH trials should move beyond histologic staging alone…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.